ClinicalTrials.gov
public full text
Public Domain
Conjunctival Vascularity Changes Usnig OCTA After Trabeculectomy
* Reduce the trauma and the time taken for patient rehabilitation. * The prevailing trend is to perform a mitomycin- C (MMC)-augmented trabeculectomy and trabeculectomy with ologen implants in a trial to decrease bleb failure as a common post- trabeculectomy complication. * Is to develop a measurement protocol by OCT-A imaging and characterization of the bleb vascularity changes in glaucoma patients before and after surgery.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Advances in Glaucoma Surgery#458494
- A First in Human Clinical Trial to Evaluate the Safety and Effectiveness of the STREAMLINE SURGICAL SYSTEM in Patients With Open-Angle Glaucoma#181626
- Evaluation of Filtering Bleb After Glaucoma Surgery by AS-OCTA#230524
- Lucentis Versus Mitomycin C During Glaucoma Surgery#861214
- Trabeculectomy Versus Canaloplasty to Treat Glaucoma#398225
Record · ID 829969
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive